RG7774
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RG7774, covering 2024-09-25 to 2024-09-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy [Phase 2]